| Vaccine Therapy, Trastuzumab, and Vinorelbine in Treating Women With Locally Recurrent or Metastatic Breast Cancer (NCT00088985) | UNC Lineberger Comprehensive Cancer Center | 2004-01-01 |
| Biomarkers in Patients With Rectal Cancer Undergoing Chemotherapy and Radiation Therapy (NCT00280761) | UNC Lineberger Comprehensive Cancer Center | 2003-12-01 |
| Induction Chemotherapy Using Paclitaxel, Carboplatin, CPT-11 With Pegfilgrastim (NCT00280787) | UNC Lineberger Comprehensive Cancer Center | 2003-11-01 |
| Bortezomib, Fluorouracil, and External-Beam Radiation Therapy in Treating Patients With Stage II, Stage III, or Stage IV Rectal Cancer (NCT00280176) | UNC Lineberger Comprehensive Cancer Center | 2003-04-01 |
| Celecoxib in Treating Patients With Relapsed Prostate Cancer Following Radiation Therapy or Radical Prostatectomy (NCT00073970) | UNC Lineberger Comprehensive Cancer Center | 2003-04-01 |
| Radiation Therapy During Surgery in Treating Older Women With Invasive Breast Cancer (NCT00182728) | UNC Lineberger Comprehensive Cancer Center | 2003-03-18 |
| Molecular Marker Profiling of Axillary Lymph Nodes in Predicting Response in Patients With Locally Advanced or Metastatic Breast Cancer Who Are Undergoing Chemotherapy Followed By Surgery (NCT00233974) | UNC Lineberger Comprehensive Cancer Center | 2002-05-01 |
| Doxorubicin Hydrochloride Liposome and Bortezomib in Treating Patients With Refractory Hematologic Cancer or Malignant Solid Tumor or Metastatic Breast Cancer (NCT00237627) | UNC Lineberger Comprehensive Cancer Center | 2001-05-01 |
| Trastuzumab and External Beam Radiation Therapy in Treating Women With Stage III or Stage IV Breast Cancer (NCT00943410) | UNC Lineberger Comprehensive Cancer Center | 2000-03-01 |
| Genistein in Treating Patients With Stage II, Stage III, or Stage IV Prostate Cancer (NCT00005827) | UNC Lineberger Comprehensive Cancer Center | 1999-12-01 |
| Capecitabine, Paclitaxel, and Trastuzumab in Treating Patients With Metastatic Breast Cancer (NCT00006108) | UNC Lineberger Comprehensive Cancer Center | 1999-08-01 |
| Multimodality Treatment for Women With Stage II, Stage III, or Stage IV Breast Cancer (NCT00006110) | UNC Lineberger Comprehensive Cancer Center | 1998-12-01 |
| Correlation of Molecular Markers With Response to Therapy and Breast Cancer Behavior (NCT01000883) | UNC Lineberger Comprehensive Cancer Center | 1998-12-01 |
| High-Dose Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Refractory Metastatic Breast Cancer (NCT00003392) | UNC Lineberger Comprehensive Cancer Center | 1997-09-01 |
| Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced or Metastatic Cancer of the Esophagus (NCT00002984) | UNC Lineberger Comprehensive Cancer Center | 1997-03-01 |
| Compassionate Use Re-Infusion of ATLCAR.CD30 (NCT03914885) | UNC Lineberger Comprehensive Cancer Center | |
| Compassionate Use of CAR T Cells Targeting the CD19 Antigen and Containing the Inducible Caspase 9 Safety Switch (NCT03594162) | UNC Lineberger Comprehensive Cancer Center | |